CONVERSATIONS THAT MATTER
Genomics is changing lives, it is reshaping economies and shifting health outcomes. B.C. is at the leading edge in the implementation of genomic research and in practice.
The role of that research in B.C. took a big leap forward when six new projects in so-called precision health care were awarded more than $60 million in funding. The money helps establish B.C. as a genomics-driven life sciences supercluster.
Precision health care is shifting the way we interact with our health, our medical practitioners and the health care system. Utilizing genomics, we can diagnose potential health threats in advance and guide treatments that are specific to individuals like you and me.
Already, the B.C. Pharmacy Association is employing pharmacogenomics to ensure you receive the right medication in the right dose at the right time. It doesn’t stop there. Treatment of childhood diseases in Indigenous populations and pharmacogenomics in childhood cancer treatment are two of the funded projects.
The investment is a validation of the extraordinary genome research underway in B.C.
We asked Genome B.C.’s chief science officer, Catalina Lopez-Correa, to join us for a Conversation That Matters about how genomics is reshaping our lives.
Simon Fraser University’s Centre for Dialogue presents Conversations That Matter. Join veteran broadcaster Stuart McNish each week for an important and engaging conversation about the issues shaping our future.